BAO PHARMA
LIVE

Serial Number

99815796

Owner

Shanghai Bao Pharmaceuticals Co., Ltd.

Attorney

Alex Patel

Filing Date

May 11, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BAO PHARMA Trademark

Serial Number: 99815796

BAO PHARMA is a trademark filed by Shanghai Bao Pharmaceuticals Co., Ltd. on May 11, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Shanghai Bao Pharmaceuticals Co., Ltd.

No. 28 Luoxin Road,

Entity Type: 99

Trademark Details

Filing Date

May 11, 2026

Registration Date

Not Registered

Goods & Services

Medicines for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Pharmaceutical preparations for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Enzymes for medical purposes; Enzyme preparations for medical purposes; Aqueous solutions for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Biochemical drugs for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Drugs for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Pharmaceutical preparations and substances for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Injectable solutions for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility; Biological preparations for medical purposes, namely, for the treatment of autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility

Filing History

APPLICATION FILING RECEIPT MAILED
May 11, 2026 MAFR
NEW APPLICATION ENTERED
May 11, 2026 NWAP